Development of an ultra-sensitive enzyme immunoassay for human insulin autoantibodies

被引：5

作者：

Numata, Satoshi ^{[2
]}

Umehara, Asako ^{[3
]}

Katakami, Hideki ^{[4
]}

Inoue, Shinobu ^{[5
]}

Hashida, Seiichi ^{[1
]}

机构：

[1] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan

[2] Kochi Univ, Dept Hlth Sci, Kochi 7818515, Japan

[3] Takamatsu Red Cross Hosp, Takamatsu, Kagawa 7600017, Japan

[4] Teikyo Univ, Dept Med, Chiba Med Ctr, Chiba 2990111, Japan

[5] Miyazaki Higashi Hosp, Natl Hosp Org, Miyazaki 8800911, Japan

来源：

CLINICAL BIOCHEMISTRY | 2012年 / 45卷 / 13-14期

关键词：

Enzyme immunoassay; Insulin antibodies; Diabetes; Graves disease; Dextran-charcoal; VIRUS TYPE-1 P24; ANTIBODIES; SERUM; ADULTS; LADA; IGG;

D O I：

10.1016/j.clinbiochem.2012.05.027

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objectives: We developed an ultrasensitive enzyme immunoassay (ICT-EIA) for insulin autoantibody (IAA) measurements to better understand the pathophysiology of diabetes. Design and methods: We developed ICT-EIA for IAA and measured IAA in 24 patients with type 1 diabetes, 30 patients with type 2 diabetes. 30 patients with methimazole-treated Graves' disease, 20 patients with Hashimoto's disease, 9 patients with hyperinsulinemia, and 73 healthy control subjects. Results: The conventional ELISA identified 3 patients with type 1 diabetes and 2 patients with type 2 diabetes as IAA positive, whereas 15 patients with type 1 diabetes, 7 patients with type 2 diabetes, and 4 patients with methimazole-treated Graves' disease were identified as IAA positive using ICT-EIA. Conclusions: The ICT-EIA is an ultrasensitive and specific assay for IAA, and its use may provide a better understanding of the role of IAA in diabetes onset and progression. (c) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：1086 / 1091

页数：6

共 16 条

[1] Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA)
Carlsson, Å
Sundkvist, G
Groop, L
Tuomi, T
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) : 76 - 80
[2] DIXON K, 1974, CLIN CHEM, V20, P1275
[3] Latent autoimmune diabetes in adults (LADA) should be less latent
Fourlanos, S
Dotta, F
Greenbaum, CJ
Palmer, JP
Rolandsson, O
Colman, PG
Harrison, LC
[J]. DIABETOLOGIA, 2005, 48 (11) : 2206 - 2212
[4] Hashida S, 1995, Biotechnol Annu Rev, V1, P403
[5] MEASUREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 P24 IN SERUM BY AN ULTRASENSITIVE ENZYME-IMMUNOASSAY, THE 2-SITE IMMUNE-COMPLEX TRANSFER ENZYME-IMMUNOASSAY
HASHIDA, S
HASHINAKA, K
NISHIKATA, I
OKA, S
SHIMADA, K
SAITOH, A
TAKAMIZAWA, A
SHINAGAWA, H
ISHIKAWA, E
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) : 298 - 303
[6] Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays
Hashida, S
Ishikawa, S
Hashinaka, K
Nishikata, I
Oka, S
Ishikawa, E
[J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) : 872 - 881
[7] SPONTANEOUS HYPOGLYCEMIA WITH INSULIN AUTOIMMUNITY IN GRAVES-DISEASE
HIRATA, Y
TOMINAGA, M
ITO, JI
NOGUCHI, A
[J]. ANNALS OF INTERNAL MEDICINE, 1974, 81 (02) : 214 - 218
[8] Genetic heterogeneity of autoimmune diabetes:: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
Horton, V
Stratton, I
Bottazzo, GF
Shattock, M
Mackay, I
Zimmet, P
Manley, S
Holman, R
Turner, R
[J]. DIABETOLOGIA, 1999, 42 (05) : 608 - 616
[9] PRINCIPLE AND APPLICATIONS OF ULTRASENSITIVE ENZYME-IMMUNOASSAY (IMMUNE-COMPLEX TRANSFER ENZYME-IMMUNOASSAY) FOR ANTIBODIES IN BODY-FLUIDS
ISHIKAWA, E
HASHIDA, S
KOHNO, T
HIROTA, K
HASHINAKA, K
ISHIKAWA, S
[J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1993, 7 (06) : 376 - 393
[10] DEVELOPMENT OF ULTRASENSITIVE ENZYME-IMMUNOASSAY REVIEWED WITH EMPHASIS ON FACTORS WHICH LIMIT THE SENSITIVITY
ISHIKAWA, E
HASHIDA, S
KOHNO, T
[J]. MOLECULAR AND CELLULAR PROBES, 1991, 5 (02) : 81 - 95

← 1 2 →